Differentiation of tuberculosis and metastatic cancer in the spine using dynamic contrast-enhanced MRI
- Author(s): Lang, N
- Su, MY
- Yu, HJ
- Yuan, H
- et al.
Published Web Locationhttps://doi.org/10.1007/s00586-015-3851-z
© 2015 Springer-Verlag Berlin Heidelberg Purpose: To investigate the differences between imaging features of spinal tuberculosis (TB) and metastatic cancer measured by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). The presentation of TB on convention MRI may not show the typical TB signs, and they may be mis-diagnosed as malignant diseases. DCE-MRI may provide additional information to help making differential diagnosis. Materials and methods: DCE-MRI was performed in 24 TB and 22 metastatic cancer patients. The DCE kinetic pattern was determined as “wash-out”, “plateau” or “persistent enhancement”. The characteristic DCE parameters were calculated from the signal intensity time course. The two-compartmental pharmacokinetic model was used to obtain Ktrans, which is the parameter associated with the delivery of MR contrast agents into the lesion, and kep, which is the parameter associated with the distribution and clearance of contrast agents from the lesion. Results: Of the 24 TB, one case showed the wash-out kinetic pattern, 12 cases showed the plateau pattern, and 11 cases showed the persistent enhancement pattern. Of the 22 metastatic cancers, 12 cases showed wash-out, 7 cases showed plateau, and 3 cases showed persistent enhancement patterns. Compared to the metastatic cancer group, the TB group had a lower kep (0.27 ± 0.15 vs. 0.49 ± 0.23 min−1, P < 0.001). The ROC analysis showed that the area under the curve was 0.780 for kep. Conclusions: DCE-MRI may provide additional information for differentiation between spinal TB and metastasis, when their manifestations on conventional imaging were similar.
Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.